
    
      This clinical trial will be conducted in healthy Korean and Caucasian volunteers at Seoul
      National University Hospital (SNUH) Clinical Trial Center.

      It is expected to take approximately 39 days from the first dosing of Investigational Product
      until the final follow-up visit. It will be hospitalized twice for 9 nights and 10 days with
      21 days of interval, and one visit will be needed for safety evaluation between 14-17 days
      from the last dosing of the Investigational Product.
    
  